Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
220.2 USD | +2.62% | +0.98% | -14.91% |
12:04am | European Commission grants marketing approval to Biogen's ALS drug | RE |
30/05 | Biogen Gets European Commission Approval for Qalsody | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.91% | 32.04B | |
-2.29% | 89.38B | |
-3.68% | 37.92B | |
+61.72% | 26.03B | |
-22.72% | 14.14B | |
-8.73% | 12.88B | |
-10.57% | 11.77B | |
+4.34% | 8.92B | |
-17.66% | 7.34B | |
+82.74% | 6.96B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Stifel Cuts Price Target on Biogen to $287 From $315, Maintains Buy Rating